Immunoprecipitation Market (2026 - 2033)

Immunoprecipitation Market Summary

The global immunoprecipitation market size was valued at USD 835.2 million in 2025 and is projected to grow from USD 882.9 million in 2026 to USD 1,301.4 million by 2033, at a CAGR of 5.7% from 2026 to 2033. North America dominated the market, accounting for the revenue share of approximately 37.0% in 2025. The increasing use of immunoprecipitation techniques in research on central nervous system disorders, cancer, and cardiovascular diseases is positively influencing the immunoprecipitation testing market.

In addition, the emerging trends in funding and investments by the government and private institutions for the research and development of next-generation DNA sequencing and genomics are driving market growth. The steady increase in the incidence of cancers, tumors, and cardiovascular diseases is the primary driver of growth in the immunoprecipitation market. The need for antigen kits, vaccines, and therapeutics is driving this expansion. Governments and certain organizations support genomics, precision medicine, and biomedical research through strategic funding initiatives to accelerate biomarker discovery and translational research. These innovations in medical instruments increase the demand for advanced molecular biology tools.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The market is being driven by the rising investment in research and development in academia, pharmaceuticals, and biotechnology companies. Scientists and healthcare professionals are seeking to understand the underlying processes of various diseases by more accurately examining tissues and molecular pathways. This has led to advancements in genetics and targeted biological treatments, as well as increased spending on biopharmaceutical R&D activities.

Government regulations and initiatives are also having a positive impact on the immunoprecipitation industry. With a focus on genomics, immunotherapy, and drug discovery, the market is poised for continued growth. As a result, immunoprecipitation is becoming an increasingly important tool for scientists and healthcare professionals working to develop new treatments and therapies for a range of diseases. In June 2024, Bio-Techne announced a strategic collaboration with the U.S. Pharmacopeia (USP) to distribute USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards alongside its analytical solutions, including the Maurice platform.

Analyst Perspective

The immunoprecipitation market is expected to grow steadily during the forecast period, driven by rising investments in proteomics, genomics, and precision medicine research. Growing efforts to understand protein-protein interactions, identify novel biomarkers, and elucidate disease mechanisms are driving the adoption of immunoprecipitation techniques. Research activities in oncology, immunology, neurology, and infectious diseases continue to expand. As a result, immunoprecipitation techniques are increasingly being used for target identification, antibody validation, and drug discovery applications. In addition, advances in the area of magnetic bead technology, high-affinity antibodies, and automated sample preparation systems have improved the sensitivity, reproducibility, throughput, and scalability of immunoprecipitation workflows.

Product Insights

The reagents product segment held the largest revenue share of 54.0% in 2025. The reagents segment is dominated by antibodies, which are used extensively for various immunoprecipitation techniques. The versatility of antibodies and the increasing adoption of immunoprecipitation methods for purifying antigen particles are key growth drivers. This variety allows researchers to select products tailored to their specific experiment requirements, enhancing the quality of their results.

The kits product segment is expected to grow at a rapid CAGR during the forecast period. The demand for immunoprecipitation kits is rising due to their ease of use, efficiency, and growing demand for advanced protein analysis in research and clinical settings. These kits simplify complex procedures, reducing the need for extensive training. Their ability to identify and separate specific proteins from complex mixtures drives demand, fueled by investments in life sciences R&D and technological advancements. For instance, in January 2024, Merck announced that the Life Science business sector entered into a non-binding Memorandum of Understanding (MoU) with Mycenax Biotech to explore cooperation to bring innovative and high-capacity bioprocessing solutions to Taiwan and other regions.

End-use Insights

The academic & research institutes segment dominated the market with the largest revenue share of approximately 45.0% in 2025, fueled by increased R&D investments and funding from government grants, donations, and private organizations. Universities and colleges are utilizing these resources to acquire and develop cutting-edge technologies, including immunoprecipitation. This influx of funding enables them to advance research topics, driving innovation and expansion in the market.

The contract research organizations (CROs) are expected to grow at the fastest CAGR of approximately 8.0% during the forecast period. CROs typically excel in various methods, including immunoprecipitation. With expertise in handling complex protein interactions, they can tailor procedures to optimize protein isolation. Outsourcing immunoprecipitation services to CROs can be a cost-effective solution for companies and research institutions, as it eliminates the need to establish an in-house laboratory and allows them to focus on core competencies.

Type Insights

The individual protein segment held the largest revenue share of approximately 29.0% in 2025. Individual protein immunoprecipitation (IP) is a precise technique for isolating target proteins from complex solutions, enabling researchers to analyze protein interactions with high specificity. This technique’s adaptability allows customization to meet experimental requirements, making it a popular choice for studies that require precise control over protein isolation. Its precision and flexibility drive its widespread adoption in research applications.

The tagged protein’s immunoprecipitation segment is expected to grow at the fastest CAGR of approximately 10.0% during the forecast period. This type enables researchers to achieve high specificity and selectivity in protein purification. By targeting and purifying the tagged receptor site, only the desired protein is isolated, resulting in high efficiency and accuracy. This technique’s versatility drives growth in the segment, making it a preferred method for researchers seeking precise protein analysis. In May 2026, GenScript Biotech Corporation announced the launch of TurboCHO Protein Expression Kit, a next-generation antibody expression reagent designed to set a new benchmark for speed, performance, output, and ease-of-use.

Regional Insights

The North America immunoprecipitation market held the largest revenue share of approximately 37.0% in 2025. This dominance can be attributed to factors such as increased expenditure by governments and the pharma and biotech firms on R&D and emergent trends, including the personalization of medicines, coupled with the enhancement of the research partnerships between the industry players and the leading academic institutions.

To learn more about this report, Download Free Sample Report

U.S. Immunoprecipitation Market Trends

The immunoprecipitation market in the U.S. accounted for the largest market revenue share in North America in 2025. The U.S. is a world center for the development of biomedical research. The growing significance of research institutions, academic facilities, and biotech businesses in the locality makes the demand for better research tools such as immunoprecipitation reagents and kits higher.

Europe Immunoprecipitation Market Trends

The immunoprecipitation market in Europe was identified as a lucrative region in 2025. Europe has been the most aggressive in investing in biotechnology research, including new immunoprecipitation technologies. The region emphasizes the scientific and technological aspects, which have resulted in the production of advanced solutions in the area of life sciences. European countries have encouraged the formation of networks and partnerships between universities, research institutions, and other players in the commercial market.

The UK immunoprecipitation market is expected to grow rapidly in the coming years due to government support and funding, strong academic and research institutes, market awareness, and adoption. Continuous advancements and heightened understanding of the immunoprecipitation techniques needed for protein purification and analysis have been a reality among the biochemical researchers and the biopharmaceutical firms located in the UK.

The immunoprecipitation market in Germany held a substantial share of the European market in 2025, owing to an emphasis on emerging technological infrastructure, successful partnerships with manufacturers, compliance with certification standards, and extensive industry expertise. In Germany, the companies have a great understanding and awareness of the market forces and the customers’ needs in the immunoprecipitation business and any other related trends.

Asia Pacific Immunoprecipitation Market Trends

The immunoprecipitation market in Asia Pacific is expected to grow at the fastest CAGR over the forecast period, owing to the rising government expenditure on life science research, primarily in the pharma and biopharma industries, along with the increasing population towards individualized treatments and advanced healthcare facilities in the Asia Pacific.

The China immunoprecipitation market is expected to grow rapidly in the coming years due to rising R&D and rising demand for biopharmaceuticals. Moreover, the increasing use of immunoprecipitation in laboratories associated with the research and development of biopharmaceuticals has further impacted the growth of this market in China positively.

The immunoprecipitation market in India is expected to grow significantly during the forecast period. Positive government regulations regarding R&D programs drive the country to build its scientific research infrastructure; there has been an increase in demand for innovative techniques such as immunoprecipitation, an edge-cutting method applicable to proteomics and genomics, among other specialized fields.

Key Immunoprecipitation Company Insights

The immunoprecipitation industry features a range of global, regional, and local players, making it a competitive market. The world’s leading companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share.

Some key companies in the immunoprecipitation market include Thermo Fisher Scientific Inc.; Abcam Limited; BioLegend, Inc.; Bio-Rad Laboratories, Inc.; and others. Companies in the industry are driving innovation through strategic partnerships, mergers, and acquisitions. Leading vendors focus on competitive enhancement, while demand for user-friendly kits grows due to ease of use, efficiency, and standardized protocols.

• BioLegend is a leading provider of biological reagents and gear that assist life science discovery from studies to cures. The company specializes in presenting world-class quality products across diverse industry areas, including immunology, neuroscience, cancer, stem cells, and cell biology. BioLegend’s reagents are known for their advanced quality and are backed by an authorized first-rate control machine.

• Thermo Fisher Scientific Inc. serves as a global provider of numerous services and products, including analytical devices, medical development solutions, area-of-expertise diagnostics, laboratory equipment, pharmaceutical services, and biotechnology offerings.

Key Immunoprecipitation Companies

The following key companies have been profiled for this study on the immunoprecipitation market:

• Thermo Fisher Scientific Inc.

• Abcam Limited

• BioLegend, Inc.

• Bio-Rad Laboratories, Inc.

• GenScript Biotech Corporation

• Merck KGaA

• Novus Biologicals

• Takara Bio Inc.

• Biologics International Corp

Recent Developments

• In May 2024, Merck KGaA announced its intention to acquire Mirus Bio, a US-based life science company. Merck KGaA’s strategic goals include expanding its presence in the life sciences sector and strengthening its capabilities in gene delivery and gene expression technologies.

Global Immunoprecipitation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global immunoprecipitation market report based on product, type, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits
  • Reagents
    • Antibodies
    • Beads
    • Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Individual Protein Immunoprecipitation
  • Protein Complex Immunoprecipitation
  • Chromatin Immunoprecipitation
  • Ribonucleoprotein Immunoprecipitation
  • Tagged Proteins Immunoprecipitation
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait